Paragon for Patients

Paragon Biosciences builds innovative companies that bring important medicines to patients. Paragon’s portfolio companies are managed by healthcare industry leaders and biotech entrepreneurs committed to delivering better outcomes. Paragon’s leadership and management team have a strong track record: 13 FDA drug approvals over the past decade, a success rate on par with much larger companies. Paragon puts its expertise to use to develop and finance innovative biotech companies and accelerate their scientific breakthroughs.

How We Work

Groundbreaking discovery requires scientific rigor, technology, and an unyielding commitment to the patients we serve.

We provide our portfolio companies with dedicated experts and cutting-edge resources. In addition, we connect our companies with entrepreneurs and clinical experts to provide the strategy, guidance, and support they need to ensure important medicines reach patients.

Our companies conduct all phases of clinical trials and development and collaborate with top medical professionals. We are relentless in applying speed and efficiency to bring novel medicines to patients in need.

Our Partners

We partner with those who share our patient-first commitment to developing new medicines.

Artboard 6.png
Artboard 5.png